Our company has independently developed all the elemental technologies, including our unique completely non-contact and non-invasive biomarker measurement technology. To further advance this technology and improve its accuracy and precision while maintaining our technical and temporal advantages, we have engaged in strategic collaborations with leading domestic research and academic institutions.
As one of these initiatives, we have completed and obtained approval for the development and optimization of a system for clinical research on our technology at an international medical institution equipped with the latest facilities in the country. Joint clinical research commenced in August (with full-scale operations beginning mid-August), officially initiated following a positive evaluation of our innovative technology.
Further communication on this matter will be provided following coordination with the university involved.
Moving forward, our company will continue to strive for enhanced technological precision, accuracy, and reliability through collaboration with prominent institutions.